Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Mot 297.10 0.82
Tata Stl 284.70 2.89
Hindalco 101.50 0.49
I T C Lt 330.15 0.53
Sterlite 83.05 0.97
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Shilpa Medicare Limited
Shilpa Medicare Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530549NSE:SHILPAMEDBloomberg:SLPA@INReuters:SHME.BO
Market Lot: 1Face Value: 2ISIN Demat: INE790G01023
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals
 
 
Recent Developments
29-MAY-13 Shilpa Medicare announced that its board of directors has recommended dividend of 65% or Rs 1.30 a share of Rs 2 each for the financial year 2012-13 19-JUL-11 Shilpa Medicare had invested in Nu Therapeutics (P), (NU) initially in the last year and now acquired controlling stake. 06-SEP-10 Shilpa Medicare, the largest manufacturer of APIs in India, today announced that it has been granted certificate of GMP Compliance from TGA Austra...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Shilpa Medicare surges on investment in Nu Therapeutics  -IRIS 19-Jul-11
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2013(12)31-Mar-2012 (12)31-Mar-2011 (12)
Net sales 3279.622784.552575.44
Other Income62.22101.5842.36
Total Income3341.842886.132617.80
Cost of goods sold2629.322218.641847.52
OPBDIT712.52667.49770.28
PAT472.12429.44509.25
Gross Block---
Equity capital49.0549.0548.05
EPS (Rs.)-17.8221.84
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-7.59 - 16.619.57 - 17.35
Debt / Equity (x)---
Operating margin (% of OI)21.323.129.4
Net margin (% of OI)14.114.919.5
Detailed Financials
Income 
Statement 		Balance Sheet Latest 
Quarterly/Halfyearly 		Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
1st Floor, 10/ 80
Rajendra Gunj
Raichur
Karnataka-584 102
PHONE
(08532) 2350 06/ 2357 04
FAX
(08532) 2358 76
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
© All rights reserved. IRIS Business Services Limited
Disclaimer